Park W, Kasi A, Spira A, Berlin J, Wang J, Herzberg B, Kuboki Y, Kitano S, Pelster M, Goldman J, Morgensztern D, Kondo S, Jänne P, Fujii H, Lee H, Gill S, Saci A, Lorusso P, Tolcher A. 608O Preliminary safety and clinical activity of ASP3082, a first-in-class, KRAS G12D selective protein degrader in adults with advanced pancreatic (PC), colorectal (CRC), and non-small cell lung cancer (NSCLC). Annals Of Oncology 2024, 35: s486-s487. DOI: 10.1016/j.annonc.2024.08.675.Peer-Reviewed Original Research